LX-7101: Clinical Trials

1 trial of LX-7101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow LX-7101: new trials by email Literature Review of LX-7101 trials Research Report on LX-7101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedLexicon Pharmaceuticals632012-03-012015-09-14

Conditions studied

Glaucoma, Open-Angle (1)  ·  Ocular Hypertension (1)

Sponsors

Lexicon Pharmaceuticals (1)

Countries

United States (1)

Top investigators

Joel Freiman, M.D., MPH (1)